Kotra Industries BhdXKLS:0002 84 Pretax Margin % is 20.65% as of Mar. 2026, which is 31% above its 10-year median of 15.78. GuruFocus rates XKLS:0002 with a GF Score™ of 84/100 and a GF Value™ of RM4.33 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 952 Drug Manufacturers companies, Kotra Industries Bhd ranks better than 83.4% on this metric.
The historical rank and industry rank for Kotra Industries Bhd's Pretax Margin % or its related term are showing as below:
XKLS:0002'
s Pretax Margin % Range Over the Past 10 Years
Min: 4.91 Med: 15.78 Max: 28.03
Current: 21.43
XKLS:0002's Pretax Margin % is ranked better than 83.4% of 952
companies
in the Drug Manufacturers industry
Industry Median: 7.295
vs XKLS:0002: 21.43
Kotra Industries Bhd (XKLS:0002) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Kotra Industries Bhd Pretax Margin % Related Terms
Kotra Industries Bhd Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Kotra Industries Bhd's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKLS:0002 vs ZTS, UTHR, VTRS: Pretax Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Kotra Industries Bhd's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kotra Industries Bhd Pretax Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Kotra Industries Bhd's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Kotra Industries Bhd's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kotra Industries Bhd (XKLS:0002) has a Pretax Margin % of 20.65% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Kotra Industries Bhd and its competitors. This is 31% above median its historical median of 15.78. Over the past decade, Kotra Industries Bhd's Pretax Margin % has ranged from 4.91 to 28.03. According to the industry distribution chart, Kotra Industries Bhd ranks #158 out of 952 companies in the Drug Manufacturers industry, placing it in the top 16.6%.
Is Kotra Industries Bhd's Pretax Margin % too high?
Kotra Industries Bhd's current Pretax Margin % of 20.65% is 31% above median its 10-year median of 15.78. Over the past 10 years, this metric has ranged from a low of 4.91 to a high of 28.03. The Drug Manufacturers industry median Pretax Margin % is 7.30. Kotra Industries Bhd's value of 20.65% is 183.1% above this industry median. Based on the distribution chart, Kotra Industries Bhd ranks #158 out of 952 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Kotra Industries Bhd has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Kotra Industries Bhd's Pretax Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Kotra Industries Bhd ranks #158 out of 952 companies for Pretax Margin %. This places Kotra Industries Bhd in the top 17% of its industry — outperforming the majority of peers. The industry median Pretax Margin % is 7.30. Kotra Industries Bhd's value of 20.65% is 183.1% above this benchmark. Historically, Kotra Industries Bhd's own Pretax Margin % has ranged from 4.91 to 28.03 over the past decade. While the company's 10-year median is 15.78 vs. the industry median of 7.30, Kotra Industries Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Drug Manufacturers company?
The median Pretax Margin % among Drug Manufacturers companies is 7.30, based on 952 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kotra Industries Bhd's current Pretax Margin % of 20.65% is 183.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Kotra Industries Bhd and its competitors. For the Drug Manufacturers industry, the median Pretax Margin % is 7.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kotra Industries Bhd's current Pretax Margin % is 20.65%, which is 31% above median its own 10-year median of 15.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kotra Industries Bhd stock overvalued right now?
Based on GuruFocus' analysis, Kotra Industries Bhd (XKLS:0002) is currently considered Modestly Undervalued. The stock's GF Value™ is RM4.33, compared to a current price of RM3.71 — trading 14.3% below its estimated fair value. The current Pretax Margin % is 20.65%, which is 31% above median its 10-year median of 15.78 and 183.1% above the Drug Manufacturers industry median of 7.30. Kotra Industries Bhd's overall GF Score™ is 84/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Kotra Industries Bhd (XKLS:0002), the current Pretax Margin % is 20.65% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kotra Industries Bhd (XKLS:0002) Overvalued in 2026?
Based on GuruFocus' analysis, Kotra Industries Bhd stock appears to be undervalued.
The current stock price of RM3.71 is trading 14.3% below its estimated GF Value™ of RM4.33.
GuruFocus considers Kotra Industries Bhd to be Modestly Undervalued.
Key valuation signals for XKLS:0002:
Pretax Margin %: 20.65% (31% above median its 10-year median of 15.78)
GF Value™: RM4.33 vs. price of RM3.71 (14.3% below fair value)
Industry Position: 183.1% above the Drug Manufacturers median (#158 of 952)
No single metric tells the full story. See the XKLS:0002 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kotra Industries Bhd is a Malaysian pharmaceutical company engaged in the development, manufacturing, and supply of pharmaceutical and healthcare products supporting all life stages. Its portfolio includes life-saving medicines, OTC supplements, and nutrition products. The Group markets three core brands: Appeton, offering health supplements and nutrition across all age groups; Vaxcel, providing injectable medicines for infectious diseases, kidney care, and gastroenterology; and Axcel, specializing in oral and topical medicines for paediatrics, dermatology, and infectious diseases. The company operates in Malaysia and overseas, with the majority of revenue derived from Malaysia.
84GF Score
Get the complete analysis for XKLS:0002
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:0002 has been successfully added to your 
